Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt
This clinical trial update reports an investigator-m masked, parallel comparison of tolerability between Combigan and Cosopt in patients wit…
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 1]
A Phase 1 trial assessing safety and intraocular pressure lowering response of brimonidine tartrate ophthalmic solution in open-angle glauco…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
A clinical trial update from Santen Inc. describes a safety and efficacy study in Phase 1/2 for open-angle glaucoma and ocular hypertension …
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost [Phase 2]
This Phase 2 trial update assesses the safety and intraocular pressure-lowering efficacy of low-dose Travoprost in patients with open-angle …
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Adjunctive Study of AL-37807 Ophthalmic Suspension [Phase 2]
A Phase 2 adjunct study of AL-37807 ophthalmic suspension for open-angle glaucoma and ocular hypertension has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
A completed clinical trial comparing the efficacy and tolerability of Ganfort (bimatoprost/timolol) versus Krytantek in Mexican patients wit…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 dose-volume study of a treatment for elevated intraocular pressure in open-angle glaucoma or ocular hypertension has been terminat…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2, Phase 3]
This document provides an update on the safety findings from Phase 2 and Phase 3 trials of anecortave acetate in patients with open-angle gl…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation [Phase 2]
Phase 2 trial update evaluating anecortave acetate for treatment of steroid-induced intraocular pressure elevation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial update assessing ocular surface tolerability of prostaglandin analogues in open-angle glaucoma or ocular hypertension; results…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension [Phase 1, Phase 2]
An update on a Phase 1/2 study evaluating ATS907 for primary open-angle glaucoma and ocular hypertension; the current status of the trial is…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]
A dose-escalation Phase 1/2 study evaluating the tolerability, safety, pharmacokinetics, and preliminary efficacy of chronic topical INO-887…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg [Phase 1, Phase 2]
Clinical trial update for SYL040012 assessing tolerance and effects on intraocular pressure in people with glaucoma or ocular hypertension (…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
The clinical trial NCT01628588 evaluating Lumigan in primary open-angle glaucoma or ocular hypertension has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
A completed clinical trial evaluating GANfort (bimatoprost/timolol) in patients with open-angle glaucoma or ocular hypertension who were ins…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
This update reports results from a completed clinical trial evaluating treatment in patients with open-angle glaucoma or ocular hypertension…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
A clinical trial evaluating Lumigan (bimatoprost) in patients with open-angle glaucoma or ocular hypertension has completed and results were…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: DuoTrav® Eye Drops As Replacement Therapy Program [Phase 4]
A Phase 4 trial evaluating DuoTrav as a replacement therapy for open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT [Phase 3]
A Phase 3 trial comparing the fixed-dose combination travoprost/brinzolamide to travoprost (Travatan) and to brinzolamide (AZOPT) in glaucom…
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [NA]
A completed clinical trial evaluated the safety and efficacy of the brimonidine tartrate/timolol fixed-dose combination in patients with gla…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects [Phase 2]
Phase 2a open-label dose-ranging study assessing safety and tolerability of ATS907 in primary open-angle glaucoma and ocular hypertension. T…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Completed clinical trial evaluating intraocular pressure reduction in newly diagnosed patients with open-angle glaucoma or ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [Phase 3]
Phase III trial evaluating a glaucoma therapy for open-angle glaucoma or ocular hypertension has completed safety and efficacy assessment. T…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 [Phase 4]
Phase 4 trial evaluating intraocular pressure lowering in open-angle glaucoma or ocular hypertension was terminated. The study enrolled Cauc…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension [Phase 4]
Phase 4 clinical trial conducted by the University of Parma evaluating 24-hour intraocular pressure control in ocular hypertension has compl…